Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Researchers Push For Independent, Long-Term Trials On Tooth Whiteners

This article was originally published in The Tan Sheet

Executive Summary

Independent, long-term clinical studies testing the efficacy and side effects of tooth whitening products on diverse populations are "urgently needed," University of Michigan researchers say after reviewing supporting literature on the products

You may also be interested in...



Shine More Safety Data On Tooth Whiteners With Hydrogen Peroxide – SCCP

The use of oral hygiene products and tooth whitening products containing more than 0.1 percent hydrogen peroxide cannot be deemed safe in the absence of long-term clinical data assessing possible adverse effects within the oral cavity, the European Commission's science panel says

Shine More Safety Data On Tooth Whiteners With Hydrogen Peroxide – SCCP

The use of oral hygiene products and tooth whitening products containing more than 0.1 percent hydrogen peroxide cannot be deemed safe in the absence of long-term clinical data assessing possible adverse effects within the oral cavity, the European Commission's science panel says

Shine More Safety Data On Tooth Whiteners With Hydrogen Peroxide – SCCP

The use of oral hygiene products and tooth whitening products containing more than 0.1 percent hydrogen peroxide cannot be deemed safe in the absence of long-term clinical data assessing possible adverse effects within the oral cavity, the European Commission's science panel says

Topics

UsernamePublicRestriction

Register

OM014079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel